CLSD — Clearside Biomedical, Inc. | ScreenerHero

CLSDClearside Biomedical, Inc.

NAS · US · Health Care · Biotechnology

0.3151USD+1.65%Mkt Cap: —P/E: —Last update: 2026-05-22

Industry Peers

Biotechnology

Vertex Pharmaceuticals Incorporated

110.61BUSDP/E 25.8

106.49BDKKP/E 20.5

Regeneron Pharmaceuticals, Inc.

66.47BUSDP/E 15.5

46.51BEURP/E 30.5

43.17BEURP/E 35.9

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

Revolution Medicines, Inc.

Camurus AB (publ)

31.18BSEKP/E 46.1

Indicators:|

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)—

Revenue/Share—

Last Price0.3151 USD

Fiscal Year End—

MR Quarter—

Employees—

CountryUS

SectorHealth Care

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.82

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-0.04

EPS (TTM)—

EPS (Forward)—

52W Range

0.03502% of range13.59

52W High13.59 USD

52W Low0.0350 USD

Profitability

Gross Margin—

Oper. Margin—

EBITDA Margin—

Profit Margin—

ROE—

ROA—

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF—

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio—

Quick Ratio—

Book Value/Sh-10.3080 USD

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.5.23M

Float—

Insiders—

Institutions—

Technical

SMA 502.869 (-89.0%)

SMA 2008.224 (-96.2%)

Beta—

S&P 52W Chg—

Avg Vol (30d)15.44K

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—